Theragen Etex Co.Ltd Total Liabilities
Theragen Etex Co.Ltd total liabilities. Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has total liabilities worth ₩101.29 Billion KRW (≈ $68.65 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Theragen Etex Co.Ltd (066700) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Theragen Etex Co.Ltd (2005–2025)
Total liabilities of Theragen Etex Co.Ltd from 2005 to 2025. This chart illustrates how Theragen Etex Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Theragen Etex Co.Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Theragen Etex Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Theragen Etex Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Polychem Indonesia Tbk
JK:ADMG
|
Indonesia | Rp44.23 Million |
|
Unitron Tech Co Ltd
KQ:142210
|
Korea | ₩439.41 Billion |
|
BrilliA Inc
NYSE MKT:BRIA
|
USA | $15.92 Million |
|
RTG Mining Inc
AU:RTG
|
Australia | AU$1.91 Million |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
Thailand | ฿2.70 Billion |
|
Hunan Tyen Machinery Co Ltd B
SHG:900946
|
China | $506.40 Million |
|
NOCTILUCA S.A. ZY -15
F:G0Z
|
Germany | €4.02 Million |
|
Sugentech Inc
KQ:253840
|
Korea | ₩18.72 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Theragen Etex Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Theragen Etex Co.Ltd balance sheet assets.
Liquidity & Leverage Metrics
Theragen Etex Co.Ltd Total Liabilities Ratios Explained
Theragen Etex Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Theragen Etex Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Theragen Etex Co.Ltd (2005–2025)
The table below shows the annual total liabilities of Theragen Etex Co.Ltd from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩98.46 Billion ≈ $66.72 Million |
-7.52% |
| 2024-12-31 | ₩106.46 Billion ≈ $72.15 Million |
+18.02% |
| 2023-12-31 | ₩90.20 Billion ≈ $61.13 Million |
-12.39% |
| 2022-12-31 | ₩102.95 Billion ≈ $69.77 Million |
-19.17% |
| 2021-12-31 | ₩127.38 Billion ≈ $86.32 Million |
-20.77% |
| 2020-12-31 | ₩160.76 Billion ≈ $108.95 Million |
+52.19% |
| 2019-12-31 | ₩105.64 Billion ≈ $71.59 Million |
+12.67% |
| 2018-12-31 | ₩93.76 Billion ≈ $63.54 Million |
+60.28% |
| 2017-12-31 | ₩58.50 Billion ≈ $39.64 Million |
-15.04% |
| 2016-12-31 | ₩68.85 Billion ≈ $46.66 Million |
-0.36% |
| 2015-12-31 | ₩69.10 Billion ≈ $46.83 Million |
+58.15% |
| 2014-12-31 | ₩43.69 Billion ≈ $29.61 Million |
+5.81% |
| 2013-12-31 | ₩41.29 Billion ≈ $27.98 Million |
-1.80% |
| 2012-12-31 | ₩42.05 Billion ≈ $28.50 Million |
-4.44% |
| 2011-12-31 | ₩44.01 Billion ≈ $29.82 Million |
-9.93% |
| 2010-12-31 | ₩48.86 Billion ≈ $33.11 Million |
+13.96% |
| 2009-12-31 | ₩42.87 Billion ≈ $29.06 Million |
-10.12% |
| 2008-12-31 | ₩47.70 Billion ≈ $32.33 Million |
+38.98% |
| 2007-12-31 | ₩34.32 Billion ≈ $23.26 Million |
+10.18% |
| 2006-12-31 | ₩31.15 Billion ≈ $21.11 Million |
-12.93% |
| 2005-12-31 | ₩35.78 Billion ≈ $24.25 Million |
-- |
About Theragen Etex Co.Ltd
Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company wa… Read more